EPIRUS Biopharmaceuticals, Inc. Accrued Liabilities, Current
EPIRUS Biopharmaceuticals, Inc. had Accrued Liabilities, Current of $2.70 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2016-05-10
- 2016-03-31: Accrued Liabilities, Current $2.70M.
- 2015-12-31: Accrued Liabilities, Current $4.00M.
- 2015-09-30: Accrued Liabilities, Current $6.42M.
- 2015-06-30: Accrued Liabilities, Current $5.27M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2016-03-31 | $2.70M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.00M 10-Q · filed 2016-05-10 | |
| 2015-09-30 | $6.42M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $5.27M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.72M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $3.23M 10-K · filed 2016-03-29 | $4.10M 10-K · filed 2015-03-31 |
| 2014-09-30 | $4.63M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.54M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.30M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $2.49M 10-K · filed 2015-03-31 | $3.34M 10-K · filed 2014-03-14 |
| 2013-09-30 | $5.20M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $5.24M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $3.52M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $4.84M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $6.09M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $4.83M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $5.73M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $6.13M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $5.43M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $4.60M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $4.27M 10-K · filed 2012-03-09 |